Search

Your search keyword '"Kurt Yuksel, Meltem"' showing total 34 results
Start Over Author "Kurt Yuksel, Meltem"
34 results on '"Kurt Yuksel, Meltem"'

2. Allogeneic Hematopoietic Stem Cell Transplantation for Primary Myelofibrosis: A 20-year Experience in a Single Center

Author

Cengiz Seval, Guldane, primary, Civriz Bozdag, Sinem, additional, Kocak Toprak, Selami, additional, Kurt Yuksel, Meltem, additional, Topcuoglu, Pervin, additional, Arslan, Onder, additional, Demirer, Taner, additional, Gurman, Gunhan, additional, Beksac, Meral, additional, Ilhan, Osman, additional, and Ozcan, Muhit, additional

Published
2023
Full Text
View/download PDF

3. The Impact of CD34+ Cell and Immunefector Cell Dose on Transplant Outcomes

Author

Koyun, Derya, primary, Cengiz, Guldane, additional, Civriz Bozdag, Sinem, additional, Toprak, Selami Kocak, additional, Topçuoğlu, Pervin, additional, Özcan, Muhit, additional, Arslan, Onder, additional, Demirer, Taner, additional, İlhan, Osman, additional, Gurman, Gunhan, additional, Beksac, Meral, additional, and Kurt Yuksel, Meltem, additional

Published
2022
Full Text
View/download PDF

4. Comparison of Salvage Autologous Hematopoietic Cell Transplantation with Outcomes Following Selinexor Combinations Among Double/Triple Refractory Myeloma Patients

Author

Cengiz, Guldane, primary, Karakaya, Bulent, additional, Yilmaz, Hulya, additional, Koyun, Derya, additional, Kircali, Ekin, additional, Basboga, Sevgi, additional, Toprak, Selami Kocak, additional, Civriz Bozdag, Sinem, additional, Kurt Yuksel, Meltem, additional, Topcuoglu, Pervin, additional, Gurman, Gunhan, additional, Kashyap, Trinayan, additional, Niblock, James, additional, and Beksac, Meral, additional

Published
2021
Full Text
View/download PDF

5. The Outcome of Autologous Hematopoietic Cell Transplantation in Elderly Patients with Aggressive Non-Hodgkin Lymphoma

Author

Ilhan, Osman, primary, Cengiz Seval, Guldane, additional, Civriz Bozdag, Sinem, additional, Toprak, Selami Kocak, additional, Kurt Yuksel, Meltem, additional, Topcuoglu, Pervin, additional, Arslan, Onder, additional, Özcan, Muhit, additional, Demirer, Taner, additional, Gurman, Gunhan, additional, and Beksac, Meral, additional

Published
2021
Full Text
View/download PDF

6. An Interim Analysis of the Turkish Myeloma Registry Among the Patients Who Have Received up to Two Lines of Therapy

Author

Sevindik, Omur Gokmen, primary, Ozkurt, Zubeyde Nur, additional, Boga, Can, additional, Besisik, Sevgi Kalayoglu, additional, Ipek, Yildiz, additional, Geduk, Ayfer, additional, Harmandali, Aybuke, additional, Salihoglu, Ayse, additional, Sahin, Handan haydaroglu, additional, Sönmez, Mehmet, additional, Vural, Filiz, additional, Akay, Olga Meltem, additional, Kurt Yuksel, Meltem, additional, Maral, Senem, additional, Ekinci, Omer, additional, Kirkizlar, Onur Hakki, additional, Tekinalp, Atakan, additional, Demir, Nazli, additional, Merter, Mustafa, additional, Saydam, Guray, additional, Alacacıoğlu, İnci, additional, Yegin, Zeynep Arzu, additional, Kasar, Mutlu, additional, Mastanzade, Metban, additional, and Ozsan, Guner Hayri, additional

Published
2021
Full Text
View/download PDF

7. Brentuximab vedotin consolidation therapy after autologous stem‐cell transplantation in patients with high‐risk Hodgkin lymphoma: Multicenter retrospective study

Author

Akay, Olga Meltem, primary, Ozbalak, Murat, additional, Pehlivan, Mustafa, additional, Yildiz, Birol, additional, Uzay, Ant, additional, Yigenoglu, Tugce Nur, additional, Elverdi, Tugrul, additional, Kaynar, Leylagul, additional, Ayyildiz, Orhan, additional, Yonal Hindilerden, Ipek, additional, Goksoy, Hasan Sami, additional, Izmir Guner, Sebnem, additional, Gunes, Ahmet Kursad, additional, Sonmez, Mehmet, additional, Kurt Yuksel, Meltem, additional, Civriz Bozdag, Sinem, additional, Ozkurt, Zubeyde Nur, additional, Toptas, Tayfur, additional, Dogu, Mehmet Hilmi, additional, Salim, Ozan, additional, Saydam, Guray, additional, Yavasoglu, Irfan, additional, Ayli, Meltem, additional, Ozet, Gulsum, additional, Albayrak, Murat, additional, Birtas Atesoglu, Elif, additional, Toprak, Selami K., additional, Yildirim, Rahsan, additional, Mehtap, Ozgur, additional, Kalayoglu Besisik, Sevgi, additional, Nalcaci, Meliha, additional, Altuntas, Fevzi, additional, and Ferhanoglu, Burhan, additional

Published
2021
Full Text
View/download PDF

8. Thyroid dysfunctions in adult patients after allogeneic hematopoietic stem cell transplantation

Author

Ataca Atilla, Pinar, primary, Akkus, Erman, additional, Atilla, Erden, additional, Gokmen, Neslihan, additional, Civriz Bozdag, Sinem, additional, Kurt Yuksel, Meltem, additional, Toprak, Selami Kocak, additional, Baskal, Nilgun, additional, Akan, Hamdi, additional, Demirer, Taner, additional, Topcuoglu, Pervin, additional, Arslan, Onder, additional, Ilhan, Osman, additional, Ozcan, Muhit, additional, Beksac, Meral, additional, and Gurman, Gunhan, additional

Published
2020
Full Text
View/download PDF

9. Blastic Plasmacytoid Dendritic Cell Neoplasm: Single Center Experience on a Rare Hematological Malignancy

Author

Narli Ozdemir, Zehra, primary, Cengiz Seval, Guldane, additional, Sahin, Ugur, additional, Uslu, Atilla, additional, Gunduz, Mehmet, additional, Civriz Bozdag, Sinem, additional, Toprak, Selami Kocak, additional, Kurt Yuksel, Meltem, additional, Topcuoglu, Pervin, additional, Kuzu, Isinsu, additional, Ozcan, Muhit, additional, Gurman, Gunhan, additional, and Ilhan, Osman, additional

Published
2020
Full Text
View/download PDF

12. Which One, Generic Vs Original Glivec Is More Effective in Patients with Chronic Myeloid Leukemia?

Author

Kircali, Ekin, primary, Cengiz Seval, Guldane, additional, Civriz Bozdag, Sinem, additional, Toprak, Selami Kocak, additional, Kurt Yuksel, Meltem, additional, Arslan, Onder, additional, Özcan, Muhit, additional, Demirer, Taner, additional, Gurman, Gunhan, additional, Ilhan, Osman, additional, Akan, Hamdi, additional, Beksac, Meral, additional, and Topcuoglu, Pervin, additional

Published
2019
Full Text
View/download PDF

13. Evaluation of Elderly Patients with Hematological Malignancies By Two Different Geriatric Risk Scoring Systems: G8 and Flemish Version of the Triage Risk Screening Tool (fTRST)

Author

Atilla, Erden, primary, Yalciner, Merih, additional, Kilic, Ozlem, additional, Muftuoglu, Nurhayat, additional, Ataca Atilla, Pinar, additional, Civriz Bozdag, Sinem, additional, Toprak, Selami Kocak, additional, Kurt Yuksel, Meltem, additional, Özcan, Muhit, additional, Gurman, Gunhan, additional, and Ilhan, Osman, additional

Published
2018
Full Text
View/download PDF

14. Impact of ABO Mismatch on Outcomes of Allogeneic Hematopoietic Stem Cell Recipients: 30 Years of Experience with 1016 Patients

Author

Atilla, Erden, primary, Topcuoglu, Pervin, additional, Akkus, Erman, additional, Ataca Atilla, Pinar, additional, Civriz Bozdag, Sinem, additional, Kurt Yuksel, Meltem, additional, Demirer, Taner, additional, Özcan, Muhit, additional, Beksac, Meral, additional, Ilhan, Osman, additional, Akan, Hamdi, additional, Arslan, Onder, additional, Gurman, Gunhan, additional, and Toprak, Selami Kocak, additional

Published
2018
Full Text
View/download PDF

16. Retrospective Analysis of 149 Unselected Patients with Mantle Cell Lymphoma Confirms Prognostic Relevance of Mantle Cell Lymphoma International Prognostic Index: Single Center Experience

Author

Cengiz Seval, Guldane, primary, Ulas, Bahar, additional, Tascı, Onur, additional, Ozel, Fulya, additional, Bulat, Buğu, additional, Kuzu, Isinsu, additional, Civriz Bozdag, Sinem, additional, Toprak, Selami Kocak, additional, Kurt Yuksel, Meltem, additional, Topcuoglu, Pervin, additional, Özcan, Muhit, additional, Beksac, Meral, additional, Ilhan, Osman, additional, Gurman, Gunhan, additional, and Arslan, Onder, additional

Published
2018
Full Text
View/download PDF

17. Comparision of Outcomes According to HLA Disparity in Acute Leukemia Patients: A Single Center Institution Experience

Author

Topcuoglu, Pervin, primary, Cengiz Seval, Guldane, additional, Civriz Bozdag, Sinem, additional, Toprak, Selami Kocak, additional, Kurt Yuksel, Meltem, additional, Dalva, Klara, additional, Arslan, Onder, additional, Özcan, Muhit, additional, Demirer, Taner, additional, Ilhan, Osman, additional, Beksac, Meral, additional, and Gurman, Gunhan, additional

Published
2018
Full Text
View/download PDF

18. Donor Lymphocyte Infusions for Relapsed Hematological Malignancies after Allogeneic Hematopoietic Stem Cell Transplantation: Single Center Experience

Author

Gurman, Gunhan, primary, Cengiz Seval, Guldane, additional, Civriz Bozdag, Sinem, additional, Toprak, Selami Kocak, additional, Kurt Yuksel, Meltem, additional, Topcuoglu, Pervin, additional, Arslan, Onder, additional, Özcan, Muhit, additional, Demirer, Taner, additional, Ilhan, Osman, additional, Beksac, Meral, additional, and Akan, Hamdi, additional

Published
2018
Full Text
View/download PDF

19. Retrospective analysis of 115 unselected patients with mantle cell lymphoma: Single center experience.

Author

Cengiz Seval, Guldane, primary, Bulat, Bugu, additional, Ozel, Fulya, additional, Tasci, Onur, additional, Kuzu, Isinsu, additional, Civriz Bozdag, Sinem, additional, Toprak, Selami Kocak, additional, Kurt Yuksel, Meltem, additional, Topcuoglu, Pervin, additional, Ozcan, Muhit, additional, Gurman, Gunhan, additional, Demirer, Taner, additional, Ilhan, Osman, additional, Akan, Hamdi, additional, Beksac, Meral, additional, and Arslan, Onder, additional

Published
2018
Full Text
View/download PDF

20. A single center experience with two decades of follow-up on patients with hairy cell leukemia.

Author

Ilhan, Osman, primary, Atilla, Erden, additional, Ataca Atilla, Pinar, additional, Civriz Bozdag, Sinem, additional, Kurt Yuksel, Meltem, additional, Toprak, Selami Kocak, additional, Topcuoglu, Pervin, additional, Demirer, Taner, additional, Arslan, Onder, additional, Ozcan, Muhit, additional, Akan, Hamdi, additional, Beksac, Meral, additional, and Gurman, Gunhan, additional

Published
2017
Full Text
View/download PDF

21. Comparison of myeloablative vs reduced intensity conditioning regimens in stem cell transplantations for acute myeloid leukemia.

Author

Gurman, Gunhan, primary, Aydemir Guloksuz, Gozde, additional, Atilla, Erden, additional, Ataca Atilla, Pinar, additional, Civriz Bozdag, Sinem, additional, Kurt Yuksel, Meltem, additional, Toprak, Selami Kocak, additional, Topcuoglu, Pervin, additional, Ozcan, Muhit, additional, Arslan, Onder, additional, Demirer, Taner, additional, Akan, Hamdi, additional, Ilhan, Osman, additional, and Beksac, Meral, additional

Published
2017
Full Text
View/download PDF

22. Therapeutic Plasma Exchange for Thrombotic Microangiopathy

Author

Ilhan, Osman, primary, Atilla, Erden, additional, Ataca Atilla, Pinar, additional, Civriz Bozdag, Sinem, additional, Kurt Yuksel, Meltem, additional, Toprak, Selami Kocak, additional, Topcuoglu, Pervin, additional, Akan, Hamdi, additional, Demirer, Taner, additional, Beksac, Meral, additional, Arslan, Onder, additional, Ozcan, Muhit, additional, and Gurman, Gunhan, additional

Published
2016
Full Text
View/download PDF

23. Comparison of Reduced Intensity Conditioning (RIC) Regimen and Myeloablative Conditioning (MAC) Regimen in Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT) for Adult Patients with Acute Leukemia

Author

Gurman, Gunhan, primary, Aydemir Guloksuz, Gozde, additional, Atilla, Erden, additional, Ataca Atilla, Pinar, additional, Civriz Bozdag, Sinem, additional, Kurt Yuksel, Meltem, additional, Toprak, Selami Kocak, additional, Topcuoglu, Pervin, additional, Arslan, Onder, additional, Ozcan, Muhit, additional, Demirer, Taner, additional, Ilhan, Osman, additional, Akan, Hamdi, additional, and Beksac, Meral, additional

Published
2016
Full Text
View/download PDF

25. Age as a decision factor for doing autologous stem cell transplantation in fit patients with myeloma and lymphoma.

Author

Ilhan, Osman, primary, Atilla, Erden, additional, Ataca, Pinar, additional, Civriz Bozdag, Sinem, additional, Toprak, Selami Kocak, additional, Kurt Yuksel, Meltem, additional, Topcuoglu, Pervin, additional, Arslan, Onder, additional, Ozcan, Muhit, additional, Demirer, Taner, additional, Akan, Hamdi, additional, Beksac, Meral, additional, and Gurman, Gunhan, additional

Published
2016
Full Text
View/download PDF

27. Comparison of Two Different Doses of Corticosteroid Premedication for Antithymocyte Globulin in Allogeneic Hematopoietic Stem Cell Transplantation

Author

Merter, Mustafa, primary, Atilla, Erden, additional, Sahin, Ugur, additional, Civriz Bozdag, Sinem, additional, Kurt Yuksel, Meltem, additional, Topcuoglu, Pervin, additional, Arslan, Onder, additional, Ozcan, Muhit, additional, Demirer, Taner, additional, Gurman, Gunhan, additional, Ilhan, Osman, additional, Akan, Hamdi, additional, Beksac, Meral, additional, and Toprak, Selami Kocak, additional

Published
2015
Full Text
View/download PDF

28. Favorable Treatment Alternative for Primary Central Nervous System Lymphoma: Combined Chemotherapy Regimen Consisting of High-Dose Methotrexate, Rituximab and Cytosine-Arabinoside

Author

Ataca, Pinar, primary, Toprak, Selami Kocak, additional, Atilla, Erden, additional, Topcuoglu, Pervin, additional, Kurt Yuksel, Meltem, additional, Kaygusuz, Gulsah, additional, Kuzu, Isinsu, additional, Arslan, Onder, additional, Ozcan, Muhit, additional, Ilhan, Osman, additional, and Konuk, Nahide, additional

Published
2014
Full Text
View/download PDF

33. Aspergillus Thyroiditis after Allogeneic Hematopoietic Stem Cell Transplantation

Author

Ataca, Pinar, Atilla, Erden, Saracoglu, Pelin, Yilmaz, Gulden, Civriz Bozdag, Sinem, Kocak Toprak, Selami, Kurt Yuksel, Meltem, Ceyhan, Koray, and Topcuoglu, Pervin

Abstract

Aspergillus thyroiditis is a rare disorder detected in immunocompromised patients during disseminated infections. Early management is essential to prevent high mortality. A 61-year-old allogeneic stem cell male recipient presented with painful thyroid nodular enlargement. He had low TSH and low free T4 levels. The thyroid ultrasound showed a hypoechoic nodule; biopsy indicated suppurative Aspergillus thyroiditis. He was successfully treated by amphotericin B.

Published
2015
Full Text
View/download PDF

34. A Teleconference With Related Donors Years After Allogeneic Hematopoietic Stem Cell Transplantation.

Author

Aydogan M, Yuksel M, Akal F, and Kurt Yuksel M

Subjects
Humans, Female, Male, Time Factors, Adult, Middle Aged, Risk Factors, Transplantation, Homologous, Return to Work, Young Adult, Activities of Daily Living, Treatment Outcome, Interviews as Topic, Living Donors, Telephone, Hematopoietic Stem Cell Transplantation adverse effects, Hematopoietic Stem Cell Transplantation psychology
Abstract

Objectives: During and after allogeneic hematopoietic stem cell donation, donors may experience adverse events. This situation can increase anxiety of candidate donors. Time to return to daily life routine and work, presentation of comorbid diseases in follow-up, and donor opinions are topics of interest., Materials and Methods: We conducted a 14-question survey among related stem cell donors between January 2010 and March 2019 by telephone interview., Results: Of 257 related donors, 175 (68.1%) were interviewed; 87 (49.7%) were female and 88 (50.3%) were male. Among donors interviewed, 144 (82.3%) donated from only peripheral blood. After harvesting of stem cells, adverse events included hip pain (38.7%), bone pain (57.2%) during mobilization, and paresthesia (28.9%) during apheresis. After apheresis, 2 serious adverse events were reported in 2 (1.3%) female donors (1 salpingo-oophorectomy and 1 nephrectomy). Splenomegaly was observed in 1 male donor (0.7%). Among donors interviewed, 77 (44%) reported being able to perform daily activities on the same day. The shortest time to daily activity was in the peripheral blood group, and the longest was in the bone marrow group (P = .001). Among working donors, 23 (27.4%) returned to work on the same day; all were peripheral blood donors. Among donors interviewed, 114 (65.1%) wanted to volunteer to donate again. One donor (0.6%) expressed guilt after donation, and 162 (92.6%) recommended other people to be stem cell donors. During the follow-up period, musculoskeletal-joint diseases increased after donation (P = .012)., Conclusions: It is important to raise awareness in society about stem cell donation and to reduce the concerns among donor candidates. Although most of the adverse events after donation are temporary and mild, a few serious adverse events in donors have been observed. Stem cell donation does not cause loss of daily activity or inability to return to the work force.

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results